Most human studies of CBD have been done on people who have seizures, and the FDA recently approved the first CBD-based drug, Epidiolex, for rare forms of epilepsy. Clinical trials for other conditions are promising, but tiny. In one Brazilian study published in 2011 of people with generalized social anxiety disorder, for example, taking a 600-mg dose of CBD (higher than a typical dose from a tincture) lessened discomfort more than a placebo, but only a dozen people were given the pill.
The FDA relies on applicants and scientific investigators to conduct research. Our role, as outlined in the Federal Food, Drug, and Cosmetic Act, is to review data submitted to the FDA in a marketing application to determine whether a proposed drug product meets the statutory standards for approval. Additional information concerning research on the medical use of marijuana is available from the National Institutes of Health, particularly the National Cancer Institute (NCI) and NIDA.
Oils are hot in the beauty world. As a beauty editor, I’ve slathered everything short of butter onto my face: argan, coconut, rosehip, sandalwood, chia, neroli, calendula, mandarin, macadamia, rice bran, seabuckthorn, patchouli, grapefruit seed, sesame seed, soybean, sweet almond, pomegranate seed, lemon myrtle, sunflower seed—even extra virgin olive oil from my pantry when I was desperate. I’ve washed my face with oil-based cleansers, and dabbed expensive mixtures being sold as “face oils” onto my skin in hopes of achieving that Instagram-ready glow. Contrary to popular belief, the right oil is actually good for your face and won’t clog your pores. Your skin needs a reasonable amount of oil to do its business; as a matter of fact, if you scrub away all your natural face oil (as I was prone to do with rubbing alcohol as a frustrated and misguided pizza-faced teen), you may actually be prone to more breakouts as your skin tries to make up for the imbalance. As cannabis meets up with the mainstream beauty world, cannabidiol (CBD) oil may be the next big thing.
Luego de agotar todas las opciones, el joven descubrió una crema de CBD en el estado de California (Estados Unidos). Solo una pequeña dosis diaria fue suficiente para aliviar inmensamente los dolores producidos por esta enfermedad. El joven se vio tan influenciado por la efectividad de dicho producto que decidió crear su propia compañía de producción de cremas de CBD, siempre con la filosofía que estas soluciones deberían estar disponible para todo aquel que lo necesite.
Cohen has found that chronic conditions including autoimmune diseases and pain syndromes can be helped with a 6-mg under-the-tongue tincture (the fastest delivery system) or a 25-mg capsule taken twice a day. Dosages for topical products like lotions are especially hard to determine—there’s no clarity on how much CBD gets into the system through the skin.
In response to the FDA’s historic decision, the Drug Enforcement Administration (DEA) announced in September 2018 that it had removed Epidiolex from Schedule I classification, a category reserved for dangerous drugs with no medical value. Henceforth, Epidiolex would be considered a Schedule V drug, the least dangerous designation under the Controlled Substances Act.
While hemp seeds are grown in many parts of the world, its major producers include Canada, France, and China. Hemp has been prohibited from cultivation in the United States since about 1950. Despite its value, the U.S. government doesn't recognize the differences between industrial hemp and marijuana. In fact, the U.S. Drug Enforcement Agency, or DEA, classifies all varieties of Cannabis as marijuana, making industrial hemp just as illegal regardless of its use.
Last year, the National Academies of Sciences, Engineering and Medicine released a nearly 500-page report on the health effects of cannabis and cannabinoids. A committee of 16 experts from a variety of scientific and medical fields analyzed the available evidence — more than 10,000 scientific abstracts in all. Because so few studies examine the effects of CBD on its own, the panel did not issue any findings about CBD specifically, but it did reach some conclusions about cannabis and cannabinoids more generally. The researchers determined that there is “conclusive or substantial evidence” supporting the use of cannabis or cannabinoids for chronic pain in adults, multiple sclerosis-related spasticity (a kind of stiffness and muscle spasms), and chemotherapy-induced nausea and vomiting. The committee also found “moderate” evidence that cannabis or cannabinoids can reduce sleep disturbances in people with obstructive sleep apnea, fibromyalgia, chronic pain and multiple sclerosis, as well as “limited” evidence that these substances can improve symptoms of Tourette’s syndrome, increase appetite and stem weight loss in people with HIV/AIDs, and improve symptoms of PTSD and anxiety.
In the meantime, some physicians are forging ahead — and cashing in. Joe Cohen is a doctor at Holos Health, a medical marijuana clinic in Boulder. I asked him what CBD is good for, and he read me a long list of conditions: pain, inflammation, nausea, vomiting, intestinal cramping, anxiety, psychosis, muscle spasms, hyperactive immune systems, nervous system degeneration, elevated blood sugar and more. He also claimed that CBD has anti-cancer properties and can regenerate brain cells and reduce the brain’s levels of amyloid beta — a kind of protein that’s been linked to Alzheimer’s disease. I asked for references, noting that most of these weren’t listed in the Academies report or a similar review published in the Journal of the American Medical Association. “I think you just have to Google search it,” he said. It’s true that a preliminary study found hints that cannabinoids might reduce beta amyloid proteins in human brain cells, but the study was done in cells grown in a lab, not in people. As for cancer, the FDA sent warning letters last year to four companies that were selling products that claimed to “prevent, diagnose, treat or cure” cancer.
One spa, Ste. Anne’s in Grafton, ON recognized early on that cannabis massage would be a sought after service and intends to introduce a CBD infused massage later this summer. Company spokeswoman Natalie Koshowski said: “It will be a relaxation massage using massage oil, salve, and aromatherapy oil to induce a deeper level of relaxation for the client. There will also be a take-home aromatherapy oil so the client can experience the relaxation benefits once they get home.” The service is expected to cost $140 plus HST for 60 minutes.